KQ-791

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameKQ-791
Drug Alias NameKQ-791
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsInsulin ResistanceDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaneq Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKaneq Bioscience Ltd
Active IndicationsN/A
Inactive IndicationsInsulin ResistanceDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A